Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Apr 12:14:25158414221083374.
doi: 10.1177/25158414221083374. eCollection 2022 Jan-Dec.

Ocular manifestations of COVID-19

Mashael Al-Namaeh  1
Affiliations
Review

Ocular manifestations of COVID-19

Mashael Al-Namaeh. Ther Adv Ophthalmol. .

Abstract

COVID-19 is a disease caused by a SARS-CoV-2 viral infection, a disease that was first detected in December 2019 in Wuhan, Hubei Province, China. COVID-19, formerly known as 2019 Novel Coronavirus (2019-nCoV) respiratory disease, was officially named COVID-19 by the World Health Organization (WHO) in February 2020. By 25 May 2021, there were 33,579,116 confirmed cases with 599,109 COVID-19 deaths worldwide. The purpose of this review article is to provide an update on what is currently known about COVID-19 ocular symptoms in adults, the elderly, and children in the literature. Finally, this article will review the eye protection precautions that should be implemented in our clinics. To assess the current literature, PubMed was searched from December 2019 to 25 May 2021. Randomized trials, observational studies, case series or case reports, letters of research, and letters to editors were selected for confirmed cases of COVID-19. According to current scientific literature since the outbreak in December 2019, 205 articles have been published. Conjunctivitis, conjunctival hyperemia, and chemosis have been reported in adults with COVID-19. There have been few studies on children and elderly patients, and further research in these age groups is needed. Finally, wearing eye protection when seeing patients on a daily basis during the pandemic is essential.

Keywords: COVID-19; SARS-CoV-2; adults; children; conjunctivitis; episcleritis; geriatric patients; ocular manifestations.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: The author declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
PRISMA 2020 flow diagram. Source: Adapted from Page et al.
See this image and copyright information in PMC

References

    1. La Distia Nora R, Putera I, Khalisha DF, et al.. Are eyes the windows to COVID-19? Systematic review and meta-analysis. BMJ Open Ophthalmol 2020; 5: e000563. DOI: 10.1136/bmjophth-2020-000563. - DOI - PMC - PubMed
    1. Wu P, Duan F, Luo C, et al.. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol 2020; 138: 575–578. DOI: 10.1001/jamaophthalmol.2020.1291. - DOI - PMC - PubMed
    1. Yahalomi T, Pikkel J, Arnon R, et al.. Central retinal vein occlusion in a young healthy COVID-19 patient: a case report. Am J Ophthalmol Case Rep 2020; 20: 100992. DOI: 10.1016/j.ajoc.2020.100992. - DOI - PMC - PubMed
    1. Koo EH, Eghrari AO, Dzhaber D, et al.. Presence of SARS-CoV-2 viral RNA in aqueous humor of asymptomatic individuals. Am J Ophthalmol 2021; 230: 151–155. DOI: 10.1016/j.ajo.2021.05.008. - DOI - PMC - PubMed
    1. Güemes-Villahoz N, Burgos-Blasco B, Arribi-Vilela A, et al.. Detecting SARS-CoV-2 RNA in conjunctival secretions: is it a valuable diagnostic method of COVID-19? J Med Virol 2021; 93: 383–388. DOI: 10.1002/jmv.26219. - DOI - PMC - PubMed

LinkOut - more resources